Korean J Neurotrauma.  2012 Apr;8(1):44-47. 10.13004/kjnt.2012.8.1.44.

Intensive Insulin Therapy after Decompression Surgery for Severe Traumatic Brain Injury

• Kim MS
• Lee SW
• Yang SH
• Hong JT
• Sung JH
• Son BC
• Lee SW

• KMID: 1427682
• DOI: http://doi.org/10.13004/kjnt.2012.8.1.44

Abstract

OBJECTIVE
The purpose of this study was to compare intensive insulin therapy and conventional therapy in terms of ventilator days, neurosurgical intensive care unit (NSICU) stay, Glasgow Outcome Scale (GOS), and complications for patients with a severe traumatic brain injury (TBI) who underwent decompressive craniectomy.
METHODS
Patients who had a TBI and a Glasgow Coma Scale (GCS) score < or =8, and who had been treated with a unilateral or bilateral decompressive craniectomy were enrolled. Twenty-three patients were treated with intensive insulin therapy targeting 80-120 mg/dL of blood glucose level. For comparison, 17 patients with conventional insulin therapy (<200 mg/dL) were extracted from the historical data.
RESULTS
There was no statistically significant difference in terms of sex, age, GCS at admission, diagnosis of TBI, and history of diabetes. There was no statistically significant difference between the conventional and intensive groups with respect to total days of mechanical ventilation, NSICU days, GOS, and pneumonia. Hypoglycemic episodes developed more frequently in the intensive insulin therapy group than in the conventional therapy group.
CONCLUSION
Intensive insulin therapy with our protocol cannot be recommended over conventional therapy in patients with severe TBI.

Keyword

Hyperglycemia; Traumatic brain injury; Intensive insulin therapy; Decompressive craniectomy

MeSH Terms

Blood Glucose
Brain Injuries
Decompression
Decompressive Craniectomy
Glasgow Coma Scale
Glasgow Outcome Scale
Humans
Hyperglycemia
Insulin
Intensive Care Units
Pneumonia
Respiration, Artificial
Ventilators, Mechanical
Blood Glucose
Insulin

Reference

1). Adams HP Jr., Adams RJ., Brott T., del Zoppo GJ., Furlan A., Goldstein LB, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 34:1056–1083.

2). Bilotta F., Caramia R., Cernak I., Paoloni FP., Doronzio A., Cuzzone V, et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. NeurocritCare. 9:159–166. 2008.

3). Bilotta F., Giovannini F., Caramia R., Rosa G. Glycemia management in neurocritical care patients: a review. JNeurosurgAnes-thesiol. 21:2–9. 2009.

4). Brunkhorst FM., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. NEnglJMed. 358:125–139. 2008.

5). Godoy DA., Di Napoli M., Rabinstein AA. Treating hyperglycemia in neurocritical patients: benefits and perils. NeurocritCare. 13:425–438. 2010.

6). Graffagnino C., Gurram AR., Kolls B., Olson DM. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes. NeurocritCare. 13:307–312. 2010.

7). Green DM., O'Phelan KH., Bassin SL., Chang CW., Stern TS., Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. NeurocritCare. 13:299–306. 2010.

8). Jeremitsky E., Omert LA., Dunham CM., Wilberger J., Rodriguez A. The impact of hyperglycemia on patients with severe brain injury. JTrauma. 58:47–50. 2005.

9). Lam AM., Winn HR., Cullen BF., Sundling N. Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg. 75:545–551. 1991.

10). Liu-DeRyke X., Collingridge DS., Orme J., Roller D., Zurasky J., Rho-ney DH. Clinical impact of early hyperglycemia during acute phase of traumatic brain injury. NeurocritCare. 11:151–157. 2009.

11). Oddo M., Schmidt JM., Carrera E., Badjatia N., Connolly ES., Presciutti M, et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. CritCareMed. 36:3233–3238. 2008.

12). Pulsinelli WA., Waldman S., Rawlinson D., Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 32:1239–1246. 1982.

13). Song EC., Chu K., Jeong SW., Jung KH., Kim SH., Kim M, et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke. 34:2215–2220. 2003.

14). van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M, et al. Intensive insulin therapy in critically ill patients. NEnglJMed. 345:1359–1367. 2001.

15). Vespa P., Boonyaputthikul R., McArthur DL., Miller C., Etchepare M., Bergsneider M, et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit CareMed. 34:850–856. 2006.

16). Welsh FA., Ginsberg MD., Rieder W., Budd WW. Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. II. Regional metabolite levels. Stroke. 11:355–363. 1980.

17). Young B., Ott L., Dempsey R., Haack D., Tibbs P. Relationship between admission hyperglycemia and neurologic outcome of severely brain-injured patients. AnnSurg. 210:466–472. discussion 472-473. 1989.

18). Zygun DA., Steiner LA., Johnston AJ., Hutchinson PJ., Al-Rawi PG., Chatfield D, et al. Hyperglycemia and brain tissue pH after traumatic brain injury. Neurosurgery. 55:877–881. discussion 882. 2004.